Sanara MedTech, Inc. (SMTI)
34.34
-0.11
(-0.32%)
USD |
NASDAQ |
Aug 24, 16:00
34.34
0.00 (0.00%)
After-Hours: 20:00
Sanara MedTech EPS Diluted (Quarterly) : -0.0523 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0523 |
| March 31, 2026 | 0.0511 |
| December 31, 2025 | -0.19 |
| September 30, 2025 | -3.517 |
| June 30, 2025 | -0.2339 |
| March 31, 2025 | -0.4116 |
| December 31, 2024 | -0.1803 |
| September 30, 2024 | -0.3355 |
| June 30, 2024 | -0.4138 |
| March 31, 2024 | -0.2095 |
| December 31, 2023 | -0.0278 |
| September 30, 2023 | -0.1273 |
| June 30, 2023 | -0.2222 |
| March 31, 2023 | -0.1441 |
| December 31, 2022 | -0.4948 |
| September 30, 2022 | -0.1814 |
| June 30, 2022 | 0.0943 |
| March 31, 2022 | -0.4114 |
| December 31, 2021 | -0.4622 |
| September 30, 2021 | -0.2687 |
| June 30, 2021 | -0.1563 |
| March 31, 2021 | -0.1734 |
| December 31, 2020 | -0.0391 |
| September 30, 2020 | -0.1841 |
| June 30, 2020 | -0.1815 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.3866 |
| December 31, 2019 | -0.5362 |
| September 30, 2019 | -0.3537 |
| June 30, 2019 | -0.1485 |
| March 31, 2019 | -38.64 |
| December 31, 2018 | 0.037 |
| September 30, 2018 | 0.022 |
| June 30, 2018 | 0.013 |
| March 31, 2018 | -0.079 |
| December 31, 2017 | 0.185 |
| September 30, 2017 | -0.082 |
| June 30, 2017 | 0.031 |
| March 31, 2017 | 0.019 |
| December 31, 2016 | 0.17 |
| September 30, 2016 | 0.098 |
| June 30, 2016 | -1.00 |
| March 31, 2016 | 0.016 |
| December 31, 2015 | -0.481 |
| September 30, 2015 | -0.233 |
| June 30, 2015 | -1.00 |
| March 31, 2015 | -0.186 |
| December 31, 2014 | -0.327 |
| September 30, 2014 | -1.00 |
| June 30, 2014 | -1.00 |
| March 31, 2014 | -1.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Intelligent Bio Solutions, Inc. | -1.345 |
| Anteris Technologies Global Corp. | -0.2989 |
| 20/20 Biolabs, Inc. | -0.2247 |
| Quest Diagnostics, Inc. | 2.848 |
| Labcorp Holdings, Inc. | 3.643 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.4111M |
| Revenue (Quarterly) | 28.14M |
| Total Expenses (Quarterly) | 28.55M |
| Enterprise Value | 349.81M |
| Gross Profit Margin (Quarterly) | 90.76% |
| Profit Margin (Quarterly) | -1.46% |
| Earnings Yield | -10.80% |
| Operating Earnings Yield | 3.82% |
| Normalized Earnings Yield | -10.09 |